VIRMA and lung adenocarcinoma: Consistently, some studies have demonstrated that the overexpression of KIAA1429 promoted cell proliferation in lung adenocarcinoma [23], diffuse large B-cell lymphoma [10], and chronic myeloid leukemia [25].